Editorials and Opinions

While new formulations of drugs can provide benefits to patients, in some cases new formulations are introduced toward the end of a drug's patent or exclusivity, a practice often referred to as "product hopping".

Americans support government action to curb prescription drug prices

Practices that undermine biopharmaceutical innovation.

Who are the largest investors in U.S. medical and health R&D?

Brand name drug price hikes are an industry-wide phenomenon.

What do cancer drugs improve?

The law reforming the pharmaceutical market in Germany (ArzneimittelmarktNeuordnungsgesetz – AMNOG) took effect in January 2011.

In the United States, list prices of on-patent medicines are rapidly increasing in some therapeutic areas.

A report by the US GAO on the Trump Administration's handling of the Orphan Drug Act.

A look at the distribution of drugs across Europe.

Two agencies, one common goal.

Older cancer drugs, higher new prices.

In wake of hit movie depicting plight of cancer patient, Chine moves to slash prices.

The prices of biologics have consistently increased over the rate-of-inflation for the past forty years.

Well, it hasn't happened.